|
1
|
Protected carotid-artery stenting versus endarterectomy in high-risk patients.
|
N Engl J Med
|
2004
|
12.58
|
|
2
|
Stenting and medical therapy for atherosclerotic renal-artery stenosis.
|
N Engl J Med
|
2013
|
8.91
|
|
3
|
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.
|
Circulation
|
2011
|
5.16
|
|
4
|
Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.
|
Circulation
|
2011
|
4.95
|
|
5
|
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
|
N Engl J Med
|
2015
|
3.69
|
|
6
|
Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study.
|
J Am Coll Cardiol
|
2005
|
2.87
|
|
7
|
Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors.
|
J Am Coll Cardiol
|
2012
|
2.85
|
|
8
|
Factors affecting long-term survival following renal artery stenting.
|
Catheter Cardiovasc Interv
|
2007
|
2.83
|
|
9
|
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2011
|
2.71
|
|
10
|
Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.
|
Circ Cardiovasc Interv
|
2011
|
2.57
|
|
11
|
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.
|
Circ Cardiovasc Interv
|
2010
|
2.52
|
|
12
|
Clinical features and outcomes of carotid artery stenting by clinical expert consensus criteria: a report from the CARE registry.
|
Catheter Cardiovasc Interv
|
2010
|
2.21
|
|
13
|
Screening for abdominal aortic aneurysm: a consensus statement.
|
J Vasc Surg
|
2004
|
1.96
|
|
14
|
Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
|
J Endovasc Ther
|
2012
|
1.95
|
|
15
|
The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit?
|
Circulation
|
2006
|
1.76
|
|
16
|
The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications.
|
Catheter Cardiovasc Interv
|
2008
|
1.75
|
|
17
|
The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.
|
Circulation
|
2012
|
1.75
|
|
18
|
Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease.
|
Catheter Cardiovasc Interv
|
2007
|
1.72
|
|
19
|
Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
|
J Vasc Surg
|
2013
|
1.68
|
|
20
|
Vascular health in Kawasaki disease.
|
J Am Coll Cardiol
|
2013
|
1.67
|
|
21
|
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.
|
J Endovasc Ther
|
2006
|
1.61
|
|
22
|
May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association.
|
Stroke
|
2009
|
1.58
|
|
23
|
Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
|
Catheter Cardiovasc Interv
|
2012
|
1.56
|
|
24
|
The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results.
|
J Vasc Interv Radiol
|
2004
|
1.55
|
|
25
|
Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials.
|
Catheter Cardiovasc Interv
|
2013
|
1.52
|
|
26
|
Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry.
|
J Vasc Interv Radiol
|
2005
|
1.51
|
|
27
|
Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
|
Crit Care Med
|
2004
|
1.47
|
|
28
|
Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry.
|
J Endovasc Ther
|
2009
|
1.47
|
|
29
|
Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis.
|
Catheter Cardiovasc Interv
|
2011
|
1.44
|
|
30
|
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
|
J Am Coll Cardiol
|
2014
|
1.43
|
|
31
|
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
|
J Nucl Cardiol
|
2015
|
1.41
|
|
32
|
Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.
|
J Clin Hypertens (Greenwich)
|
2014
|
1.40
|
|
33
|
Risk adjustment for case mix and the effect of surgeon volume on morbidity.
|
JAMA Surg
|
2013
|
1.40
|
|
34
|
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
1.36
|
|
35
|
Protected carotid stenting in high-risk patients with severe carotid artery stenosis.
|
J Am Coll Cardiol
|
2006
|
1.31
|
|
36
|
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging.
|
Circulation
|
2011
|
1.23
|
|
37
|
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline).
|
Vasc Med
|
2011
|
1.19
|
|
38
|
Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial.
|
Catheter Cardiovasc Interv
|
2008
|
1.13
|
|
39
|
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.
|
J Vasc Surg
|
2011
|
1.13
|
|
40
|
Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.
|
Am Heart J
|
2013
|
1.12
|
|
41
|
Inferior vena cava filters.
|
JACC Cardiovasc Interv
|
2013
|
1.11
|
|
42
|
Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease.
|
Circulation
|
2006
|
1.11
|
|
43
|
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
|
Catheter Cardiovasc Interv
|
2008
|
1.10
|
|
44
|
Clinical competence statement on carotid stenting: training and credentialing for carotid stenting--multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to develop a clinical competence statement on carotid interventions.
|
J Am Coll Cardiol
|
2005
|
1.07
|
|
45
|
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies.
|
J Am Coll Cardiol
|
2013
|
1.07
|
|
46
|
The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008.
|
Prev Chronic Dis
|
2011
|
1.07
|
|
47
|
Spontaneous blue finger syndrome: a benign process.
|
Am J Med
|
2012
|
0.99
|
|
48
|
Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study.
|
Catheter Cardiovasc Interv
|
2009
|
0.99
|
|
49
|
Noninvasive diagnostic strategies for peripheral arterial disease.
|
Cleve Clin J Med
|
2006
|
0.97
|
|
50
|
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
|
Circulation
|
2014
|
0.96
|
|
51
|
The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism.
|
Hosp Pract (1995)
|
2014
|
0.95
|
|
52
|
Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications.
|
Catheter Cardiovasc Interv
|
2014
|
0.94
|
|
53
|
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.
|
Catheter Cardiovasc Interv
|
2011
|
0.94
|
|
54
|
Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study.
|
JACC Cardiovasc Interv
|
2011
|
0.94
|
|
55
|
Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial.
|
Catheter Cardiovasc Interv
|
2010
|
0.94
|
|
56
|
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease).
|
J Am Coll Cardiol
|
2011
|
0.93
|
|
57
|
The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
|
Fertil Steril
|
2004
|
0.93
|
|
58
|
StarClose vascular closure system (VCS) is safe and effective in patients who ambulate early following successful femoral artery access closure--results from the RISE clinical trial.
|
Catheter Cardiovasc Interv
|
2011
|
0.90
|
|
59
|
Vascular disorders in athletes.
|
Vasc Med
|
2010
|
0.90
|
|
60
|
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease).
|
Circulation
|
2011
|
0.89
|
|
61
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
Circulation
|
2010
|
0.89
|
|
62
|
SCAI expert consensus statement for renal artery stenting appropriate use.
|
Catheter Cardiovasc Interv
|
2014
|
0.89
|
|
63
|
Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia.
|
J Am Coll Cardiol
|
2013
|
0.89
|
|
64
|
Medical treatment of peripheral arterial disease: a comprehensive review.
|
J Vasc Interv Radiol
|
2004
|
0.88
|
|
65
|
Atherosclerotic renal artery stenosis and renal artery stenting: an evolving therapeutic option.
|
Expert Rev Cardiovasc Ther
|
2011
|
0.88
|
|
66
|
Associations of cardiovascular risk factors with two surrogate markers of subclinical atherosclerosis: endothelial function and carotid intima media thickness.
|
Atherosclerosis
|
2011
|
0.88
|
|
67
|
Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.
|
Catheter Cardiovasc Interv
|
2014
|
0.88
|
|
68
|
Postgraduate training in vascular medicine: proposed requirements and standards.
|
Vasc Med
|
2003
|
0.87
|
|
69
|
Percutaneous revascularization of occluded renal arteries in the setting of acute renal failure.
|
Vasc Med
|
2009
|
0.87
|
|
70
|
External iliac artery endofibrosis in an amateur runner: hemodynamic, angiographic, histopathological evaluation and percutaneous revascularization.
|
Vasc Med
|
2007
|
0.87
|
|
71
|
Inferior vena cava filters: truth or dare?
|
Circ Cardiovasc Interv
|
2013
|
0.87
|
|
72
|
SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use.
|
Catheter Cardiovasc Interv
|
2014
|
0.87
|
|
73
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
J Am Coll Cardiol
|
2010
|
0.87
|
|
74
|
Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.
|
Circulation
|
2008
|
0.86
|
|
75
|
Nonatherosclerotic arterial disorders of the lower extremities.
|
Circulation
|
2012
|
0.86
|
|
76
|
Segmental arterial mediolysis: clinical and imaging features at presentation and during follow-up.
|
J Vasc Interv Radiol
|
2011
|
0.84
|
|
77
|
Clinical risk predictors for cerebral hyperperfusion syndrome after carotid endarterectomy.
|
J Neurol Neurosurg Psychiatry
|
2012
|
0.84
|
|
78
|
Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease.
|
J Vasc Access
|
2014
|
0.84
|
|
79
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
Vasc Med
|
2010
|
0.84
|
|
80
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). Developed in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition. Endorsed by the American Academy of Podiatric Practice Management.
|
J Vasc Surg
|
2010
|
0.84
|
|
81
|
Live case demonstrations: attitudes and ethical implications for practice.
|
Ann Vasc Surg
|
2011
|
0.84
|
|
82
|
Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
|
J Endovasc Ther
|
2014
|
0.83
|
|
83
|
A multidisciplinary pulmonary embolism response team.
|
Chest
|
2013
|
0.82
|
|
84
|
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
|
Thromb Haemost
|
2004
|
0.82
|
|
85
|
Case records of the Massachusetts General Hospital. Case 7-2007. A 59-year-old woman with diabetic renal disease and nonhealing skin ulcers.
|
N Engl J Med
|
2007
|
0.82
|
|
86
|
Renal artery stenosis: searching for the algorithms for diagnosis and treatment.
|
J Am Coll Cardiol
|
2003
|
0.82
|
|
87
|
Atherosclerotic Vascular Disease Conference: Writing Group IV: imaging.
|
Circulation
|
2004
|
0.82
|
|
88
|
Renovascular hypertension.
|
Expert Rev Cardiovasc Ther
|
2005
|
0.81
|
|
89
|
Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
|
J Endovasc Ther
|
2014
|
0.81
|
|
90
|
Comprehensive medical management of peripheral arterial disease.
|
Prog Cardiovasc Dis
|
2011
|
0.80
|
|
91
|
An evidence-based score to detect prevalent peripheral artery disease (PAD).
|
Vasc Med
|
2012
|
0.80
|
|
92
|
Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial.
|
EuroIntervention
|
2010
|
0.80
|
|
93
|
Treatment strategies for peripheral artery disease.
|
Expert Opin Pharmacother
|
2009
|
0.80
|
|
94
|
Detection of common carotid artery stenosis using duplex ultrasonography: a validation study with computed tomographic angiography.
|
J Vasc Surg
|
2009
|
0.80
|
|
95
|
SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use.
|
Catheter Cardiovasc Interv
|
2014
|
0.79
|
|
96
|
Accelerated thrombolysis for pulmonary embolism: will clinical benefit be ULTIMAtely realized?
|
Circulation
|
2013
|
0.79
|
|
97
|
Correlates of carotid stenosis in patients undergoing coronary artery bypass grafting--a case control study.
|
Vasc Med
|
2009
|
0.78
|
|
98
|
SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use.
|
Catheter Cardiovasc Interv
|
2014
|
0.78
|
|
99
|
Unprotected carotid artery stenting in modern practice.
|
Catheter Cardiovasc Interv
|
2013
|
0.78
|
|
100
|
Catch-22: Carotid stenting is safe and effective (Food and Drug Administration) but is it reasonable and necessary (Centers for Medicare and Medicaid Services)?
|
JACC Cardiovasc Interv
|
2012
|
0.78
|
|
101
|
Renal artery revascularization: collaborative approaches for specialists.
|
Adv Chronic Kidney Dis
|
2008
|
0.78
|
|
102
|
Treating large pulmonary emboli: do the guidelines guide us?
|
Curr Opin Pulm Med
|
2013
|
0.77
|
|
103
|
Unusual causes of intermittent claudication: popliteal artery entrapment syndrome, cystic adventitial disease, fibromuscular dysplasia, and endofibrosis.
|
Curr Treat Options Cardiovasc Med
|
2009
|
0.77
|
|
104
|
Anatomic correlates of supra-normal ankle brachial indices.
|
Catheter Cardiovasc Interv
|
2013
|
0.77
|
|
105
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
J Vasc Nurs
|
2011
|
0.77
|
|
106
|
Peripheral artery disease and genetics: is there a cause-and-effect relationship?
|
Postgrad Med
|
2010
|
0.77
|
|
107
|
ACR Appropriateness Criteria(®) on suspected lower extremity deep vein thrombosis.
|
J Am Coll Radiol
|
2011
|
0.77
|
|
108
|
Treatment of renal artery in-stent restenosis with sirolimus-eluting stents.
|
Vasc Med
|
2009
|
0.76
|
|
109
|
Introduction to expert consensus statements for peripheral interventions from the Society for Cardiovascular Angiography and Interventions.
|
Catheter Cardiovasc Interv
|
2014
|
0.76
|
|
110
|
Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials.
|
Catheter Cardiovasc Interv
|
2010
|
0.76
|
|
111
|
Pharmacologic and clinical characteristics of thrombolytic agents.
|
Rev Cardiovasc Med
|
2002
|
0.76
|
|
112
|
Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.
|
J Vasc Interv Radiol
|
2013
|
0.76
|
|
113
|
The association between peripheral artery and lumbar spine disease: a single-center study.
|
Am J Med
|
2012
|
0.76
|
|
114
|
The FReedom from Ischemic Events-New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease.
|
BMC Cardiovasc Disord
|
2013
|
0.75
|
|
115
|
Re: The American "board" of vascular medicine: questions and concerns.
|
J Vasc Interv Radiol
|
2006
|
0.75
|
|
116
|
The breakthrough balloon for critical limb ischemia?
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
117
|
Interventional cardiology: Renal artery stenting--which patients will benefit?
|
Nat Rev Cardiol
|
2009
|
0.75
|
|
118
|
Renal artery stenosis: what we don't know won't hurt us. ...right?
|
Catheter Cardiovasc Interv
|
2007
|
0.75
|
|
119
|
Secondary prevention after ischemic stroke.
|
N Engl J Med
|
2012
|
0.75
|
|
120
|
Vasa vasorum enhancement on computerized tomographic angiography correlates with symptomatic patients with 50% to 70% carotid artery stenosis.
|
Stroke
|
2013
|
0.75
|
|
121
|
The top 12 advances in vascular medicine.
|
J Endovasc Ther
|
2004
|
0.75
|
|
122
|
Lack of Association Between Limb Hemodynamics and Response to Infrapopliteal Endovascular Therapy in Patients With Critical Limb Ischemia.
|
J Invasive Cardiol
|
2017
|
0.75
|
|
123
|
Renal artery duplex ultrasound criteria for the detection of significant in-stent restenosis.
|
Catheter Cardiovasc Interv
|
2013
|
0.75
|
|
124
|
Carotid duplex ultrasound velocity measurements versus intravascular ultrasound in detecting carotid in-stent restenosis.
|
Circ Cardiovasc Interv
|
2009
|
0.75
|
|
125
|
Ultrasound-Guided Arterial Access: Outcomes Among Patients With Peripheral Artery Disease and Critical Limb Ischemia Undergoing Peripheral Interventions.
|
J Invasive Cardiol
|
2016
|
0.75
|
|
126
|
The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.
|
Catheter Cardiovasc Interv
|
2008
|
0.75
|
|
127
|
Treatment of Submassive Pulmonary Embolism: Knowing When to be Aggressive and When to be Conservative.
|
Curr Treat Options Cardiovasc Med
|
2015
|
0.75
|
|
128
|
Images in cardiovascular medicine. Adventitial fibromuscular dysplasia of the renal artery: management challenges of nonatherosclerotic renal artery stenosis.
|
Circulation
|
2009
|
0.75
|
|
129
|
An 82-year-old woman with worsening hypertension: review of renal artery stenosis.
|
JAMA
|
2008
|
0.75
|
|
130
|
Carotid stent restenosis--a problem in search of a cure?
|
Catheter Cardiovasc Interv
|
2007
|
0.75
|
|
131
|
Endovascular management of acute limb ischemia.
|
Ann Vasc Surg
|
2011
|
0.75
|
|
132
|
Surveillance imaging for carotid in-stent restenosis.
|
Catheter Cardiovasc Interv
|
2006
|
0.75
|
|
133
|
The current management of aortic, common iliac, and external iliac artery disease: basic data underlying clinical decision making.
|
Ann Vasc Surg
|
2011
|
0.75
|
|
134
|
Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat".
|
Tech Vasc Interv Radiol
|
2010
|
0.75
|
|
135
|
Carotid stenting with embolic protection: evolutionary advances.
|
Expert Rev Med Devices
|
2008
|
0.75
|
|
136
|
Blood pressure surges during office-based transurethral microwave therapy for the prostate.
|
Mayo Clin Proc
|
2008
|
0.75
|
|
137
|
Interventional stroke therapy: current state of the art and needs assessment.
|
Catheter Cardiovasc Interv
|
2007
|
0.75
|
|
138
|
Transient ischemic attacks in a 22-year-old.
|
Am J Med
|
2012
|
0.75
|
|
139
|
Safety and Performance of Lithoplasty for Treatment of Calcified Peripheral Artery Lesions.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
140
|
Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trial.
|
J Interv Cardiol
|
2010
|
0.75
|
|
141
|
Introduction.
|
Prog Cardiovasc Dis
|
2011
|
0.75
|
|
142
|
Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease.
|
J Vasc Surg
|
2009
|
0.75
|
|
143
|
Medical management of venous thromboembolic disease.
|
Tech Vasc Interv Radiol
|
2004
|
0.75
|
|
144
|
Images in vascular medicine. Penile ischemic lesions associated with anti-phospholipid antibody syndrome.
|
Vasc Med
|
2011
|
0.75
|